Impact of Preoperative Medical Therapy for Surgical Site Infection in Children with Ulcerative Colitis: A Single-Center Experience

Backgrounds: We aimed to investigate the relationship between preoperative immunomodulator administration and occurrence of Surgical Site Infection (SSI) in pediatric Ulcerative Colitis (UC) patients. Methods: We evaluated SSI occurrence after total proctocolectomy with ileal J-pouch anal anastomosis and creation of diversion ileostomy at the first stage in pediatric UC 24 patients. SSI was defined as an infection occurring within 30 days after operation. The relationships between SSI occurrence and preoperative medical therapy were reviewed. Keiichi Uchida1*, Yuhki Koike1, Mikihiro Inoue1, Kohei Otake1, Kohei Matsushita1, Kiyoshi Hashimoto1, Yuka Nagano1, Toshimitsu Araki1, Yoshiki Okita1, Mikio Kawamura1, Minako Kobayashi1 , Yuji Toiyama1, Yasuhiko Mohri1 and Masato Kusunoki1 1Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Japan *Corresponding author: Keiichi Uchida, Department of Gastrointestinal and Pediatric Surgery, Mie University Graduate School of Medicine, Japan, Tel: +81-59-231-5294; Fax: +81-59-232-6968; Email: [email protected] Published Date: May 10, 2016 Gr up SM